115 related articles for article (PubMed ID: 35920594)
1. Prognostic value of texture analysis of the primary tumour in high-risk neuroblastoma: An
Fiz F; Bottoni G; Bini F; Cerroni F; Marinozzi F; Conte M; Treglia G; Morana G; Sorrentino S; Garaventa A; Siri G; Piccardo A
Pediatr Blood Cancer; 2022 Nov; 69(11):e29910. PubMed ID: 35920594
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
Wang G; Si Y; Liu J; Wang W; Yang J
Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, Treatment Response, and Prognosis: The Role of
Piccardo A; Morana G; Puntoni M; Campora S; Sorrentino S; Zucchetta P; Ugolini M; Conte M; Cistaro A; Ferrarazzo G; Pescetto M; Lattuada M; Bottoni G; Garaventa A; Giovanella L; Lopci E
J Nucl Med; 2020 Mar; 61(3):367-374. PubMed ID: 31541036
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Interim 18F-DOPA and 18F-FDG PET/CT Findings in Stage 3-4 Pediatric Neuroblastoma.
Ko KY; Yen RF; Ko CL; Chou SW; Chang HH; Yang YL; Jou ST; Hsu WM; Lu MY
Clin Nucl Med; 2022 Jan; 47(1):21-25. PubMed ID: 34874346
[TBL] [Abstract][Full Text] [Related]
5. Association of
Önner H; Coskun N; Erol M; Eren Karanis Mİ
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):11-16. PubMed ID: 34991831
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
Piccardo A; Puntoni M; Lopci E; Conte M; Foppiani L; Sorrentino S; Morana G; Naseri M; Cistaro A; Villavecchia G; Fanti S; Garaventa A
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1046-56. PubMed ID: 24562643
[TBL] [Abstract][Full Text] [Related]
7. Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
Liu CJ; Lu MY; Liu YL; Ko CL; Ko KY; Tzen KY; Chang HH; Yang YL; Jou ST; Hsu WM; Yen RF
Clin Nucl Med; 2017 Mar; 42(3):e142-e148. PubMed ID: 28072621
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of intratumoral heterogeneity of preoperative
Kim BS; Kim SJ
Hell J Nucl Med; 2021; 24(3):172-177. PubMed ID: 34901957
[TBL] [Abstract][Full Text] [Related]
9. Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.
Abenavoli EM; Linguanti F; Anichini M; Miele V; Mungai F; Palazzo M; Nassi L; Puccini B; Romano I; Sordi B; Sciagrà R; Simontacchi G; Vannucchi AM; Berti V
Hematol Oncol; 2024 Mar; 42(2):e3261. PubMed ID: 38454623
[TBL] [Abstract][Full Text] [Related]
10. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
11. Prognostic value of
Hotta M; Minamimoto R; Gohda Y; Miwa K; Otani K; Kiyomatsu T; Yano H
Ann Nucl Med; 2021 Jul; 35(7):843-852. PubMed ID: 33948903
[TBL] [Abstract][Full Text] [Related]
12. Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
Yoon HJ; Kim Y; Chung J; Kim BS
Breast J; 2019 May; 25(3):373-380. PubMed ID: 29602210
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Functional Parameters of
Wang M; Xu H; Xiao L; Song W; Zhu S; Ma X
Contrast Media Mol Imaging; 2019; 2019():2641627. PubMed ID: 31427906
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma.
Hyun SH; Kim HS; Choi SH; Choi DW; Lee JK; Lee KH; Park JO; Lee KH; Kim BT; Choi JY
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1461-8. PubMed ID: 26872788
[TBL] [Abstract][Full Text] [Related]
15. Texture analysis of
Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
[TBL] [Abstract][Full Text] [Related]
16. Radiomics analysis of pre-treatment [
van Helden EJ; Vacher YJL; van Wieringen WN; van Velden FHP; Verheul HMW; Hoekstra OS; Boellaard R; Menke-van der Houven van Oordt CW
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2307-2317. PubMed ID: 30094460
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of
Liu J; Si Y; Zhou Z; Yang X; Li C; Qian L; Feng LJ; Zhang M; Zhang SX; Liu J; Kan Y; Gong J; Yang J
Cancer Imaging; 2022 Jul; 22(1):32. PubMed ID: 35791003
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Values of Primary Tumor Textural Heterogeneity and Blood Biomarkers in High-risk Neuroblastoma.
Vural O; Aydos U; Okur A; Pinarli FG; Atay LÖ
J Pediatr Hematol Oncol; 2023 Oct; 45(7):383-391. PubMed ID: 37027243
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET/computed tomography images of largest metastatic lymph node.
Ishiwata Y; Kaneta T; Nawata S; Iizuka H; Utsunomiya D
Nucl Med Commun; 2021 Jan; 42(1):86-92. PubMed ID: 33044405
[TBL] [Abstract][Full Text] [Related]
20. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
